Trastornos de pánico

Referencias

Artículos principales

Roy-Byrne PP, Wagner AW, Schraufnagel TJ. Understanding and treating panic disorder in the primary care setting. J Clin Psychiatry. 2005;66 Suppl 4:16-22. Resumen

Roy-Byrne P, Craske MG, Sullivan G, et al. Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial. JAMA. 2010 May 19;303(19):1921-8. Resumen

Craske MG, Stein MB, Sullivan G, et al. Disorder-specific impact of coordinated anxiety learning and management treatment for anxiety disorders in primary care. Arch Gen Psychiatry. 2011 Apr;68(4):378-88.Texto completo  Resumen

Katzman MA, Bleau P, Blier P, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry. 2014;14 Suppl 1:S1.Texto completo  Resumen

Barlow DH, Gorman JM, Shear MK, et al. Cognitive-behavioral therapy, imiprimine, or their combination for panic disorder: a randomized controlled trial. JAMA. 2000 May 17;283(19):2529-36.Texto completo  Resumen

Roy-Byrne PP, Craske MG, Stein MB, et al. A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder. Arch Gen Psychiatry. 2005 Mar;62(3):290-8.Texto completo  Resumen

Artículos de referencia

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., (DSM-5). Washington, DC: American Psychiatric Publishing; 2013.

2. Olaya B, Moneta MV, Miret M, et al. Epidemiology of panic attacks, panic disorder and the moderating role of age: results from a population-based study. J Affect Disord. 2018 Dec 1;241:627-33. Resumen

3. de Jonge P, Roest AM, Lim CC, et al. Cross-national epidemiology of panic disorder and panic attacks in the world mental health surveys. Depress Anxiety. 2016 Dec;33(12):1155-77.Texto completo  Resumen

4. Beesdo K, Knappe S, Pine DS. Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V. Psychiatr Clin North Am. 2009 Sep;32(3):483-524.Texto completo  Resumen

5. Kessler RC, Chiu WT, Jin R, et al. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2006 Apr;63(4):415-24.Texto completo  Resumen

6. Grant BF, Hasin DS, Stinson FS, et al. The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006 Mar;67(3):363-74. Resumen

7. Goodwin RD, Faravelli C, Rosi S, et al. The epidemiology of panic disorder and agoraphobia in Europe. Eur Neuropsychopharmacol. 2005 Aug;15(4):435-43. Resumen

8. Kroenke K, Spitzer RL, Williams JB, et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007 Mar 6;146(5):317-25. Resumen

9. Roy-Byrne PP, Wagner AW, Schraufnagel TJ. Understanding and treating panic disorder in the primary care setting. J Clin Psychiatry. 2005;66 Suppl 4:16-22. Resumen

10. Clayton AH, Stewart RS, Fayyad R, et al. Sex differences in clinical presentation and response in panic disorder: pooled data from sertraline treatment studies. Arch Womens Ment Health. 2006 May;9(3):151-7. Resumen

11. Hammerness P, Harpold T, Petty C, et al. Characterizing non-OCD anxiety disorders in psychiatrically referred children and adolescents. J Affect Disord. 2008 Jan;105(1-3):213-9. Resumen

12. Goodwin RD, Lieb R, Hoefler M, et al. Panic attack as a risk factor for severe psychopathology. Am J Psychiatry. 2004 Dec;161(12):2207-14. Resumen

13. Cosci F, Knuts IJ, Abrams K, et al. Cigarette smoking and panic: a critical review of the literature. J Clin Psychiatry. 2010 May;71(5):606-15. Resumen

14. Rodriguez BF, Bruce SE, Pagano ME, et al. Relationships among psychosocial functioning, diagnostic comorbidity, and the recurrence of generalized anxiety disorder, panic disorder, and major depression. J Anxiety Disord. 2005;19(7):752-66. Resumen

15. Roy-Byrne PP, Stein MB, Russo J, et al. Panic disorder in the primary care setting: comorbidity, disability, service utilization, and treatment. J Clin Psychiatry. 1999 Jul;60(7):492-9. Resumen

16. Hettema JM, Neale NC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry. 2001 Oct;158(10):1568-78. Resumen

17. Kendler KS, Neale MC, Kessler RC, et al. Panic disorder in women: a population-based twin study. Psychol Med. 1993 May;23(2):397-406. Resumen

18. Roy-Byrne PP, Craske MG, Stein M. Panic disorder. Lancet. 2006 Sep 16;368(9540):1023-32. Resumen

19. Barlow DH. Anxiety and its disorders. 2nd ed. New York: Guilford Press; 2002.

20. Leskin GA, Sheikh JI. Lifetime trauma history and panic disorder: findings from the National Comorbidity Survey. J Anxiety Disord. 2002;16(6):599-603. Resumen

21. Clark DA, Beck AT. Cognitive therapy of anxiety disorders: science and practice. New York, NY: The Guilford Press; 2010.

22. Schmidt NB, Lerew DR, Jackson RJ. Prospective evaluation of anxiety sensitivity in the pathogenesis of panic: replication and extension. J Abnorm Psychol. 1999 Aug;108(3):532-7. Resumen

23. Naragon-Gainey K. Meta-analysis of the relations of anxiety sensitivity to the depressive and anxiety disorders. Psychol Bull. 2010 Jan;136(1):128-50. Resumen

24. Gorman JM, Kent JM, Sullivan GM, et al. Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry. 2000 Apr;157(4):493-505. Resumen

25. Roy-Byrne PP, Cowley DS. Search for pathophysiology of panic disorder. Lancet. 1998 Nov 21;352(9141):1646-7. Resumen

26. Abelson JL, Khan S, Liberzon I, et al. HPA axis activity in patients with panic disorder: review and synthesis of four studies. Depress Anxiety. 2007;24(1):66-76.Texto completo  Resumen

27. Kircher T, Arolt V, Jansen A, et al. Effect of cognitive-behavioral therapy on neural correlates of fear conditioning in panic disorder. Biol Psychiatry. 2013 Jan 1;73(1):93-101. Resumen

28. Reinecke A, Thilo K, Filippini N, et al. Predicting rapid response to cognitive-behavioural treatment for panic disorder: the role of hippocampus, insula, and dorsolateral prefrontal cortex. Behav Res Ther. 2014 Nov;62:120-8. Resumen

29. Hirshfeld DR, Smoller JW, Fredman SJ, et al. Early antecedents of panic disorder: genes, childhood, and the environment. In: Rosenbaum JF, Pollack MH, eds. Panic disorder and its treatment. New York, NY: Marcel Dekker Inc; 1998:93-152.

30. Goodwin RD, Eaton WW. Asthma and the risk of panic attacks among adults in the community. Psychol Med. 2003 Jul;33(5):879-85. Resumen

31. Niccolai V, van Duinen MA, Griez EJ. Respiratory patterns in panic disorder reviewed: a focus on biological challenge tests. Acta Psychiatr Scand. 2009 Sep;120(3):167-77. Resumen

32. Zvolensky MJ, Feldner MT, Leen-Feldner EW, et al. Smoking and panic attacks, panic disorder, and agoraphobia: a review of the empirical literature. Clin Psychol Rev. 2005 Sep;25(6):761-89. Resumen

33. Vilarim MM, Rocha Araujo DM, Nardi AE. Caffeine challenge test and panic disorder: a systematic literature review. Expert Rev Neurother. 2011 Aug;11(8):1185-95. Resumen

34. Filho AS, Maciel BC, Martin-Santos R, et al. Does the association between mitral valve prolapse and panic disorder really exist? Prim Care Companion J Clin Psychiatry. 2008;10(1):38-47.Texto completo  Resumen

35. Craske MG, Tsao JC. Assessment and treatment of nocturnal panic attacks. Sleep Med Rev. 2005 Jun;9(3):173-84. Resumen

36. Isensee B, Wittchen HU, Stein MB, et al. Smoking increases the risk of panic: findings from a prospective community study. Arch Gen Psychiatry. 2003 Jul;60(7):692-700.Texto completo  Resumen

37. Lewis-Fernández R, Hinton DE, Laria AJ, et al. Culture and the anxiety disorders: recommendations for DSM-V. Depress Anxiety. 2010 Feb;27(2):212-29.Texto completo  Resumen

38. Hollifield M, Finley MR, Skipper B. Panic disorder phenomenology in urban self-identified Caucasian-Non-Hispanics and Caucasian-Hispanics. Depress Anxiety. 2003;18(1):7-17. Resumen

39. Hinton DE, Chhean D, Pich V, et al. Neck-focused panic attacks among Cambodian refugees: a logistic and linear regression analysis. J Anxiety Disord. 2006;20(2):119-38. Resumen

40. Hinton DE, Chhean D, Fama JM, et al. Gastrointestinal-focused panic attacks among Cambodian refugees: associated psychopathology, flashbacks, and catastrophic cognitions. J Anxiety Disord. 2007;21(1):42-58. Resumen

41. Smith LC, Friedman S, Nevid J. Clinical and sociocultural differences in African American and European American patients with panic disorder and agoraphobia. J Nerv Ment Dis. 1999 Sep;187(9):549-60. Resumen

42. Seguí J, Salvador-Carulla I, García I, et al. Semiology and subtyping of panic disorders. Acta Psychiatr Scand. 1998 Apr;97(4):272-7. Resumen

43. Neerakal I, Srinivasan K. A study of the phenomenology of panic attacks in patients from India. Psychopathology. 2003 Mar-Apr;36(2):92-7. Resumen

44. Shiori T, Someya T, Murashita S, et al. The symptom structure of panic disorder: a trial using factor and cluster analysis. Acta Psychiatr Scand. 1996 Feb;93(2):80-6. Resumen

45. Weber BE, Kapoor WN. Evaluation and outcomes of patients with palpitations. Am J Med. 1996 Feb;100(2):138-48. Resumen

46. Katerndahl DA. Chest pain and its importance in patients with panic disorder: an updated literature review. Prim Care Companion J Clin Psychiatry. 2008;10(5):376-83.Texto completo  Resumen

47. Spitzer RL, Kroenke K, Williams JB; Patient Health Questionnaire Primary Care Study Group. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999 Nov 10;282(18):1737-44.Texto completo  Resumen

48. Furukawa TA, Katherine Shear M, Barlow DH, ET AL. Evidence-based guidelines for interpretation of the Panic Disorder Severity Scale. Depress Anxiety. 2009;26(10):922-9.Texto completo  Resumen

49. Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7.Texto completo  Resumen

50. Barsky AJ, Delamater BA, Orav JE. Panic disorder patients and their medical care. Psychosomatics. 1999 Jan-Feb;40(1):50-6. Resumen

51. Doyle A, Pollack MH. Long-term management of panic disorder. J Clin Psychiatry. 2004;65 Suppl 5:24-8. Resumen

52. Cloos JM. The treatment of panic disorder. Curr Opin Psychiatry. 2005 Jan;18(1):45-50. Resumen

53. National Institute for Health and Care Excellence. Generalised anxiety disorder and panic disorder in adults: management. July 2019 [internet publication].Texto completo

54. Batelaan NM, Bosman RC, Muntingh A, et al. Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials. BMJ. 2017 Sep 13;358:j3927.Texto completo  Resumen

55. Roy-Byrne P, Craske MG, Sullivan G, et al. Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial. JAMA. 2010 May 19;303(19):1921-8. Resumen

56. Sullivan G, Craske MG, Sherbourne C, et al. Design of the Coordinated Anxiety Learning and Management (CALM) study: innovations in collaborative care for anxiety disorders. Gen Hosp Psychiatry. 2007 Sep-Oct;29(5):379-87.Texto completo  Resumen

57. Craske MG, Stein MB, Sullivan G, et al. Disorder-specific impact of coordinated anxiety learning and management treatment for anxiety disorders in primary care. Arch Gen Psychiatry. 2011 Apr;68(4):378-88.Texto completo  Resumen

58. Rollman BL, Belnap BH, Mazumdar S, et al. Telephone-delivered stepped collaborative care for treating anxiety in primary care: a randomized controlled trial. J Gen Intern Med. 2017 Mar;32(3):245-55.Texto completo  Resumen

59. Rollman BL, Herbeck Belnap B, Abebe KZ, et al. Effectiveness of online collaborative care for treating mood and anxiety disorders in primary care: a randomized clinical trial. JAMA Psychiatry. 2018 Jan 1;75(1):56-64.Texto completo  Resumen

60. Bandelow B, Sagebiel A, Belz M, et al. Enduring effects of psychological treatments for anxiety disorders: meta-analysis of follow-up studies. Br J Psychiatry. 2018 Jun;212(6):333-8. Resumen

61. Andrews G, Bell C, Boyce P, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder. Australian & New Zealand Journal of Psychiatry. 2018;52(12):1109-1172.Texto completo

62. Munjack DJ, Crocker B, Cabe D, et al. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks. J Clin Psychopharmacol. 1989 Feb;9(1):22-7. Resumen

63. Sharp DM, Power KG, Swanson V. Reducing therapist contact in cognitive behaviour therapy for panic disorder and agoraphobia in primary care: global measures of outcome in a randomised controlled trial. Br J Gen Pract. 2000 Dec;50(461):963-8.Texto completo  Resumen

64. Febbraro GA. An investigation into the effectiveness of bibliotherapy and minimal contact interventions in the treatment of panic attacks. J Clin Psychol. 2005 Jun;61(6):763-79. Resumen

65. Febbraro GA, Clum GA, Roodman AA, et al. The limits of bibliotherapy: a study of the differential effectiveness of self-administered interventions in individuals with panic attacks. Beh Ther. 1999;30(2):209-22.

66. The Reading Agency (UK). Reading Well Books on Prescription scheme. 2018 [internet publication].Texto completo

67. Lewis C, Pearce J, Bisson JI. Efficacy, cost-effectiveness and acceptability of self-help interventions for anxiety disorders: systematic review. Br J Psychiatry. 2012 Jan;200(1):15-21. Resumen

68. Andrisano C, Chiesa A, Serretti A. Newer antidepressants and panic disorder: a meta-analysis. Int Clin Psychopharmacol. 2013 Jan;28(1):33-45. Resumen

69. Hofmann SG, Sawyer AT, Korte KJ, et al. Is it beneficial to add pharmacotherapy to cognitive-behavioral therapy when treating anxiety disorders? A meta-analytic review. Int J Cogn Ther. 2009 Jan 1;2(2):160-75.Texto completo  Resumen

70. Katzman MA, Bleau P, Blier P, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry. 2014;14 Suppl 1:S1.Texto completo  Resumen

71. Barlow DH, Gorman JM, Shear MK, et al. Cognitive-behavioral therapy, imiprimine, or their combination for panic disorder: a randomized controlled trial. JAMA. 2000 May 17;283(19):2529-36.Texto completo  Resumen

72. Otto MW, Deveney C. Cognitive-behavioral therapy and the treatment of panic disorder: efficacy and strategies. J Clin Psychiatry. 2005;66 Suppl 4:28-32. Resumen

73. Sánchez-Meca J, Rosa-Alcázar AI, Marín-Martínez F, et al. Psychological treatment of panic disorder with or without agoraphobia: a meta-analysis. Clin Psychol Rev. 2010 Feb;30(1):37-50. Resumen

74. Marchand A, Roberge P, Primiano S, et al. A randomized, controlled clinical trial of standard, group and brief cognitive-behavioral therapy for panic disorder with agoraphobia: a two-year follow-up. J Anxiety Disord. 2009 Dec;23(8):1139-47. Resumen

75. Roy-Byrne PP, Craske MG, Stein MB, et al. A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder. Arch Gen Psychiatry. 2005 Mar;62(3):290-8.Texto completo  Resumen

76. Gloster AT, Wittchen HU, Einsle F, et al. Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT. J Consult Clin Psychol. 2011 Jun;79(3):406-20. Resumen

77. de Beurs E, van Balkom AJ, Lange A, et al. Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone. Am J Psychiatry. 1995 May;152(5):683-91. Resumen

78. van Apeldoorn FJ, van Hout WJ, Mersch PP, et al. Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia. Acta Psychiatr Scand. 2008 Apr;117(4):260-70. Resumen

79. Rosenbaum JF, Fredman SJ, Pollack MH. The pharmacotherapy of panic disorder. In: Rosenbaum JF, Pollack MH, eds. Panic disorder and its treatment. New York, NY: Marcel Dekker Inc.; 1998:153-80.

80. Furukawa TA, Watanabe N, Churchill R. Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review. Br J Psychiatry. 2006 Apr;188:305-12. Resumen

81. Bandelow B, Seidler-Brandler U, Becker A, et al. Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders. World J Biol Psychiatry. 2007;8(3):175-87. Resumen

82. Furukawa TA, Watanabe N, Churchill R. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004364.Texto completo  Resumen

83. Otto MW, Pollack MH, Sachs GS, et al. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. Am J Psychiatry. 1993 Oct;150(10):1485-90. Resumen

84. Spiegel DA, Bruce TJ. Benzodiazepines and exposure-based cognitive-behavior therapies for panic disorder: conclusions from combined treatment trials. Am J Psychiatry. 1997 Jun;154(6):773-81. Resumen

85. Bakker A, van Balkom AJ, Stein DJ. Evidence-based pharmacotherapy of panic disorder. Int J Neuropsychopharmacol. 2005 Sep;8(3):473-82. Resumen

86. Bradwejn J, Ahokas A, Stein DJ, et al. Venlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study. Br J Psychiatry. 2005 Oct;187:352-9.Texto completo  Resumen

87. Batelaan NM, Van Balkom AJ, Stein DJ. Evidence-based pharmacotherapy of panic disorder: an update. Int J Neuropsychopharmacol. 2012 Apr;15(3):403-15.Texto completo  Resumen

88. Freire RC, Hallak JE, Crippa JA, et al. New treatment options for panic disorder: clinical trials from 2000 to 2010. Expert Opin Pharmacother. 2011 Jun;12(9):1419-28. Resumen

89. Roy-Byrne PP, Cowley DS. Pharmacological treatments for panic disorder, generalized anxiety disorder, specific phobia, and social anxiety disorder. In: Nathan P, Gorman JM, eds. A guide to treatments that work. 3rd ed. New York, NY: Oxford University Press; 2007:337-66.

90. Ballenger JC, Davidson JR, Lecrubier Y, et al. Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 1998;59 Suppl 8:47-54. Resumen

91. Pollack MH, Otto MW, Worthington JJ, et al. Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial. Arch Gen Psychiatry. 1998 Nov;55(11):1010-6.Texto completo  Resumen

92. Michelson D, Allgulander C, Dantendorfer K, et al. Efficacy of usual antidepressant dosing regimens of fluoxetine in panic disorder: randomized, placebo-controlled trial. Br J Psychiatry. 2001 Dec;179:514-8.Texto completo  Resumen

93. Backish D, Hooper CL, Filteau MJ, et al. A double-blind placebo-controlled trial comparing fluvoxamine and imiprimine in the treatment of panic disorder with or without agoraphobia. Psychopharmacol Bull. 1996;32(1):135-41. Resumen

94. Leinonen E, Lepola U, Koponen H, et al. Citalopram controls phobic symptoms in patients with panic disorder: randomized controlled trial. J Psychiatry Neurosci. 2000 Jan;25(1):24-32.Texto completo  Resumen

95. Stahl SM, Gergel I, Li D. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2003 Nov;64(11):1322-7. Resumen

96. Mochcovitch MD, Nardi AE. Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies. Expert Rev Neurother. 2010 Aug;10(8):1285-93. Resumen

97. Breilmann J, Girlanda F, Guaiana G, et al. Benzodiazepines versus placebo for panic disorder in adults. Cochrane Database Syst Rev. 2019 Mar 28;3:CD010677.Texto completo  Resumen

98. Royal Australian College of General Practitioners. Prescribing drugs of dependence in general practice, Part B - benzodiazepines. Jun 2015 [internet publication].Texto completo

99. Moylan S, Giorlando F, Nordfjærn T, et al. The role of alprazolam for the treatment of panic disorder in Australia. Aust N Z J Psychiatry. 2012 Mar;46(3):212-24. Resumen

100. Moylan S, Staples J, Ward SA, et al. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder. J Clin Psychopharmacol. 2011 Oct;31(5):647-52. Resumen

101. Kennedy KM, O'Riordan J. Prescribing benzodiazepines in general practice. Br J Gen Pract. 2019 Mar;69(680):152-153.Texto completo  Resumen

102. Worthington JJ 3rd, Pollack MH, Otto MW, et al. Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder. Psychopharmacol Bull. 1998;34:199-205. Resumen

103. Hermos JA, Young MM, Lawler EV, et al. Characterizations of long-term anxiolytic benzodiazepine prescriptions in veteran patients. J Clin Psychopharmacol. 2005;25:600-604. Resumen

104. Means-Christensen AJ, Roy-Byrne PP, Sherbourne CD, et al. Relationships among pain, anxiety, and depression in primary care. Depress Anxiety. 2008;25(7):593-600. Resumen

105. Caillard V, Rouillon F, Viel JF, et al. Comparative effects of low and high doses of clomipramine and placebo in panic disorder: a double-blind controlled study. Acta Psychiatr Scand. 1999 Jan;99(1):51-8. Resumen

106. Rush AJ. STAR*D: what have we learned? Am J Psychiatry. 2007 Feb;164(2):201-4. Resumen

107. Rathgeb-Fuetsch M, Kempter G, Feil A, et al. Short- and long- term efficacy of cognitive behavioral therapy for DSM-IV panic disorder in patients with and without severe psychiatric comorbidity. J Psychiatr Res. 2011 Sep;45(9):1264-8. Resumen

108. Emmrich A, Beesdo-Baum K, Gloster AT, et al. Depression does not affect the treatment outcome of CBT for panic and agoraphobia: results from a multicenter randomized trial. Psychother Psychosom. 2012;81(3):161-72. Resumen

109. Bystritsky A. Treatment-resistant anxiety disorders. Mol Psychiatry. 2006 Sep;11(9):805-14. Resumen

110. Goddard AW, Brouette T, Almai A, et al. Early coadministration of clonazepam with sertraline for panic disorder. Arch Gen Psychiatry. 2001 Jul;58(7):681-6.Texto completo  Resumen

111. Sheehan DV, Raj AB, Harnett-Sheehan K, et al. The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study. Acta Psychiatr Scand. 1993 Jul;88(1):1-11. Resumen

112. Moroz G, Rosenbaum JF. Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages. J Clin Psychiatry. 1999 Sep;60(9):604-12. Resumen

113. Schweizer E, Fox I, Case G, et al. Lorazepam vs. alprazolam in the treatment of panic disorder. Psychopharmacol Bull. 1988;24(2):224-7. Resumen

114. Otto MW, Tolin DF, Nations KR, et al. Five sessions and counting: considering ultra-brief treatment for panic disorder. Depress Anxiety. 2012 Jun;29(6):465-70. Resumen

115. Lessard MJ, Marchand A, Pelland MÈ, et al. Comparing two brief psychological interventions to usual care in panic disorder patients presenting to the emergency department with chest pain. Behav Cogn Psychother. 2012 Mar;40(2):129-47. Resumen

116. Gallo KP, Chan PT, Buzzella BA, et al. The impact of an 8-day intensive treatment for adolescent panic disorder and agoraphobia on comorbid diagnoses. Behav Ther. 2012 Mar;43(1):153-9.Texto completo  Resumen

117. Firth J, Torous J, Nicholas J, et al. Can smartphone mental health interventions reduce symptoms of anxiety? A meta-analysis of randomized controlled trials. J Affect Disord. 2017 Aug 15;218:15-22.Texto completo  Resumen

118. Van Singer M, Chatton A, Khazaal Y. Quality of smartphone apps related to panic disorder. Front Psychiatry. 2015 Jul 14;6:96.Texto completo  Resumen

119. Carlbring P, Bohman S, Brunt S, et al. Remote treatment of panic disorder: a randomized trail of internet-based cognitive behavior therapy supplemented with telephone calls. Am J Psychiatry. 2006 Dec;163(12):2119-25. Resumen

120. Cuijpers P, Marks IM, van Straten A, et al. Computer-aided psychotherapy for anxiety disorders: a meta-analytic review. Cogn Behav Ther. 2009;38(2):66-82. Resumen

121. Hedman E, Ljótsson B, Lindefors N. Cognitive behavior therapy via the Internet: a systematic review of applications, clinical efficacy and cost-effectiveness. Expert Rev Pharmacoecon Outcomes Res. 2012 Dec;12(6):745-64. Resumen

122. Pande AC, Pollack MH, Crockatt J, et al. Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol. 2000 Aug;20(4):467-71. Resumen

123. Mula M, Pini S, Cassano GB. The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence. J Clin Psychopharmacol. 2007 Jun;27(3):263-72. Resumen

124. Croom KF, Perry CM, Plosker GL. Mirtazapine: a review of its use in major depression and other psychiatric disorders. CNS Drugs. 2009;23(5):427-52. Resumen

125. Serretti A, Chiesa A, Calati R, et al. Novel antidepressants and panic disorder: evidence beyond current guidelines. Neuropsychobiology. 2011;63(1):1-7.Texto completo  Resumen

126. Fava GA, Zielezny M, Savron G, et al. Long-term effects of behavioural treatment for panic disorder with agoraphobia. Br J Psychiatry. 1995 Jan;166(1):87-92. Resumen

127. Brown TA, Barlow DH. Long-term outcome in cognitive-behavioral treatment of panic disorder: clinical predictors and alternative strategies for assessment. J Consult Clin Psychol. 1995 Oct;63(5):754-65. Resumen

128. Ballenger JC, Pecknold J, Rickels K, et al. Medication discontinuation in panic disorder. J Clin Psychiatry. 1993 Oct;54 Suppl:15-21. Resumen

129. Reisman Y. Post-SSRI sexual dysfunction. BMJ. 2020 Feb 27;368:m754.Texto completo  Resumen

130. Reisman Y. Sexual Consequences of Post-SSRI Syndrome. Sex Med Rev. 2017 Oct;5(4):429-433.Texto completo  Resumen

131. Serretti A, Porcelli S. Antidepressant induced weight gain. BMJ. 2018 May 23;361:k2151. Resumen

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad